Covifor: Current Affairs, GK & News - 2020-2021
Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment
Published: June 22, 2020
For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic ..
Month: Current Affairs - June, 2020
Category: Science & Technology Current Affairs
Topics: Central Drugs Standard Control Organisation (CDSCO) • COVID-19 • Covifor • Drug Controller General of India • Gilead Science • Hepatitis C • Hetero Pharmaceuticals • Japan • Remdesivir • Russia • Singapore • United States • Visakhapatnam